This flow blocking electrode technology is designed to provide precise control over blood flow during vascular and interventional procedures, offering medical professionals a safer and more effective tool for managing blood flow in critical interventions. The electrode is engineered to temporarily block flow in a specific region, allowing for enhanced precision and reducing risks during procedures such as catheter insertions, stent placements, and vascular surgeries. For companies in the medical device and healthcare industries, this technology provides an innovative solution to improve patient outcomes and enhance procedural safety.
Controlling blood flow during vascular and interventional procedures is critical for minimizing complications, preventing blood loss, and ensuring accurate device placements. However, traditional methods for blocking or managing blood flow during these procedures can be invasive, time-consuming, and prone to risks such as clot formation or vessel damage. Physicians and surgeons need more reliable tools that allow them to temporarily and effectively block blood flow in specific areas, giving them greater control over the procedure while reducing the risk of complications.
This flow blocking electrode technology addresses these challenges by providing a highly effective and minimally invasive method for controlling blood flow in a specific area during medical procedures. The electrode works by generating an electrical signal that temporarily blocks flow in targeted blood vessels, giving medical professionals the control they need to perform delicate interventions safely and efficiently. This device offers improved precision, reducing the likelihood of complications such as excessive bleeding or unintended vessel damage. Additionally, the electrode’s design makes it easy to integrate into existing vascular tools and devices, streamlining the overall procedure.
For medical device manufacturers, this flow blocking electrode represents a significant advancement in vascular care, offering a new tool that enhances safety and effectiveness in critical procedures. Healthcare providers, including vascular surgeons and interventional cardiologists, can benefit from the electrode’s ability to improve procedural control, reduce complications, and shorten recovery times for patients. This technology also offers potential applications in diagnostics, where precise control of blood flow can improve imaging and treatment accuracy.
Licensing this flow blocking electrode technology positions your company at the forefront of medical innovation in vascular care. By providing a safer, more effective tool for managing blood flow during critical interventions, this technology supports better patient outcomes, reduces procedural risks, and enhances the precision of vascular procedures. It is a valuable investment for medical device companies looking to lead in the development of cutting-edge solutions for healthcare professionals and their patients.
What is claimed is:
1. An electrosurgical wand comprising:
Flow blocking electrode
Johnson E. Goode, Kyle Alan Kapchinski, Melissa Trott Davis
Smith and Nephew Inc
11234753
February 1, 2022
Learn more about "Innovative Flow Blocking Electrode for Vascular Care"